Peptide receptor radionuclide therapy (PRRT) in radioiodine-refractory thyroid cancer: A case report of significant response to lu177 DOTA-TATE treatment

A 59-year-old woman with follicular thyroid carcinoma underwent total thyroidectomy followed by radioiodine treatment. Following treatment, the whole-body scan did not show any abnormal radioiodine uptake. However, during the follow-up, the serum thyroglobulin (Tg) value increased without detectable...

Descripción completa

Detalles Bibliográficos
Autores principales: Ataei-Nakhaei, Saeideh, Aryana, Kamran, Mostafavi, Sayyed Mostafa, Kosari, Hadis Mohammadzadeh, Esmatinia, Mohammad, Aghaee, Atena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832896/
https://www.ncbi.nlm.nih.gov/pubmed/35315988
http://dx.doi.org/10.20945/2359-3997000000451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832896/
https://www.ncbi.nlm.nih.gov/pubmed/35315988
http://dx.doi.org/10.20945/2359-3997000000451

Ejemplares similares